SAM
DGX icon

Shell Asset Management’s Quest Diagnostics DGX Stock Holding History

Shell Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$642K Sell
3,371
-1,350
-29% -$240K 0.06% 303
2025
Q2 		$848K Buy
4,721
+1,846
+64% +$321K 0.03% 396
2025
Q1 		$486K Hold
2,875
– – 0.02% 476
2024
Q4 		$434K Hold
2,875
– – 0.02% 542
2024
Q3 		$446K Buy
+2,875
New +$429K 0.02% 532
2024
Q1 		$394K Sell
2,875
-1,086
-27% -$141K 0.02% 555
2023
Q4 		$546K Sell
3,961
-202
-5% -$26.6K 0.03% 486
2023
Q3 		$507K Buy
4,163
+112
+3% +$14.9K 0.02% 562
2023
Q2 		$569K Sell
4,051
-5,256
-56% -$725K 0.02% 523
2023
Q1 		$1.32M Sell
9,307
-34
-0.4% -$4.86K 0.05% 323
2022
Q4 		$1.46M Sell
9,341
-1,513
-14% -$217K 0.06% 300
2022
Q3 		$1.33M Sell
10,854
-3,519
-24% -$463K 0.05% 327
2022
Q2 		$1.91M Buy
14,373
+3,569
+33% +$486K 0.06% 316
2022
Q1 		$1.48M Sell
10,804
-1,448
-12% -$202K 0.03% 390
2021
Q4 		$2.12M Buy
12,252
+5,807
+90% +$884K 0.04% 345
2021
Q3 		$937K Sell
6,445
-713
-10% -$104K 0.02% 539
2021
Q2 		$945K Sell
7,158
-1,427
-17% -$187K 0.02% 600
2021
Q1 		$1.1M Sell
8,585
-13,811
-62% -$1.7M 0.02% 500
2020
Q4 		$2.67M Sell
22,396
-7,714
-26% -$940K 0.06% 335
2020
Q3 		$3.45M Buy
30,110
+12,373
+70% +$1.46M 0.08% 241
2020
Q2 		$2.02M Sell
17,737
-17,062
-49% -$1.81M 0.05% 318
2020
Q1 		$2.79M Sell
34,799
-797
-2% -$82.5K 0.08% 254
2019
Q4 		$3.8M Sell
35,596
-2,496
-7% -$260K 0.08% 272
2019
Q3 		$4.08M Sell
38,092
-4,354
-10% -$447K 0.09% 248
2019
Q2 		$4.32M Sell
42,446
-12,407
-23% -$1.19M 0.1% 240
2019
Q1 		$4.93M Sell
54,853
-1,384
-2% -$120K 0.11% 227
2018
Q4 		$4.68M Buy
56,237
+1,931
+4% +$181K 0.12% 213
2018
Q3 		$5.86M Buy
54,306
+899
+2% +$98.6K 0.12% 213
2018
Q2 		$5.87M Sell
53,407
-9,860
-16% -$1.03M 0.12% 215
2018
Q1 		$6.35M Hold
63,267
– – 0.13% 202
2017
Q4 		$6.23M Buy
63,267
+4,425
+8% +$419K 0.12% 208
2017
Q3 		$5.51M Sell
58,842
-3,254
-5% -$345K 0.12% 205
2017
Q2 		$6.9M Buy
62,096
+516
+0.8% +$54.6K 0.15% 185
2017
Q1 		$6.05M Buy
61,580
+6,316
+11% +$602K 0.13% 192
2016
Q4 		$5.08M Sell
55,264
-11,604
-17% -$1M 0.12% 203
2016
Q3 		$5.66M Buy
66,868
+5,220
+8% +$438K 0.12% 210
2016
Q2 		$5.02M Buy
61,648
+2,391
+4% +$182K 0.12% 199
2016
Q1 		$4.23M Sell
59,257
-2,557
-4% -$171K 0.1% 210
2015
Q4 		$4.4M Sell
61,814
-167,375
-73% -$11.3M 0.1% 192
2015
Q3 		$13.9M Buy
229,189
+113,228
+98% +$7.91M 0.22% 95
2015
Q2 		$8.41M Sell
115,961
-24,812
-18% -$1.83M 0.17% 140
2015
Q1 		$10.8M Sell
140,773
-18,659
-12% -$1.34M 0.19% 130
2014
Q4 		$10.7M Sell
159,432
-69,757
-30% -$4.4M 0.17% 136
2014
Q3 		$13.9M Buy
229,189
+2,189
+1% +$135K 0.22% 97
2014
Q2 		$13.3M Sell
227,000
-2,801
-1% -$164K 0.21% 103
2014
Q1 		$13.3M Sell
229,801
-390
-0.2% -$20.9K 0.22% 95
2013
Q4 		$12.3M Buy
230,191
+153,656
+201% +$9.11M 0.21% 94
2013
Q3 		$4.73M Buy
76,535
+209
+0.3% +$12.5K 0.09% 250
2013
Q2 		$4.63M Buy
+76,326
New +$4.55M 0.09% 252

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Shell Asset Management's DGX Position: Q3 2025 in Review

Shell Asset Management reduced its Quest Diagnostics (DGX) stake by 29% in Q3 2025, selling an estimated $240K and leaving 3,371 shares worth $642K. The position accounts for 0.06% of the portfolio, ranked #303.

Shell Asset Management first reported a position in DGX in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.9M in Q3 2015. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Shell Asset Management held 3,371 shares of Quest Diagnostics worth $642K as of Q3 2025.
  • Shell Asset Management sold 1,350 Quest Diagnostics shares in Q3 2025, an estimated $240K.
  • Quest Diagnostics made up 0.06% of Shell Asset Management's portfolio in Q3 2025, its #303 holding.
  • Shell Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's Quest Diagnostics position peaked at $13.9M in Q3 2015.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.